Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE BOBAY JEGAT : revenue, balance sheet and financial ratios

PHARMACIE BOBAY JEGAT is a French company founded 30 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in FALAISE (14700), this company of category PME shows in 2016 a revenue of 1.0 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE BOBAY JEGAT (SIREN 407655117)
Indicator 2020 2016
Revenue N/C 1 048 324 €
Net income 7 692 € 11 806 €
EBITDA N/C 41 597 €
Net margin N/C 1.1%

Revenue and income statement

In 2020, PHARMACIE BOBAY JEGAT generates positive net income of 8 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2020: 12 k€ -> 8 k€.

Net income (2020) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

7 692 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 185%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 28%. The balance between equity and debt is satisfactory.

Debt ratio (2020) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

184.73%

Financial autonomy (2020) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

28.304%

Asset age ratio (2020) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

1.4%

Solvency indicators evolution
PHARMACIE BOBAY JEGAT

Sector positioning

Debt ratio
184.73 2020
2016
2020
Q1: 33.22
Med: 96.81
Q3: 238.41
Average +15 pts over 2 years

In 2020, the debt ratio of PHARMACIE BOBAY JEGAT (184.73) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
28.3% 2020
2016
2020
Q1: 23.59%
Med: 41.65%
Q3: 61.93%
Average -15 pts over 2 years

In 2020, the financial autonomy of PHARMACIE BOBAY JEGAT (28.3%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
10.11 years 2016
2016
Q1: 2.17 years
Med: 6.32 years
Q3: 11.13 years
Average

In 2016, the repayment capacity of PHARMACIE BOBAY JEGAT (10.11) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 127.37. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2020) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

127.373

Liquidity indicators evolution
PHARMACIE BOBAY JEGAT

Sector positioning

Liquidity ratio
127.37 2020
2016
2020
Q1: 133.13
Med: 181.9
Q3: 251.9
Watch

In 2020, the liquidity ratio of PHARMACIE BOBAY JEGAT (127.37) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Interest coverage
18.2x 2016
2016
Q1: 4.69x
Med: 10.82x
Q3: 19.32x
Good

In 2016, the interest coverage of PHARMACIE BOBAY JEGAT (18.2x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2020) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2020) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2020) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2020) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
PHARMACIE BOBAY JEGAT

Positioning of PHARMACIE BOBAY JEGAT in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 180 transactions of similar company sales in 2020, the value of PHARMACIE BOBAY JEGAT is estimated at 108 708 € (range 72 485€ - 146 676€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2020
180 transactions
72k€ 108k€ 146k€
108 708 € Range: 72 485€ - 146 676€
NAF 5 année 2020

Valuation method used

Net Income Multiple
7 692 € × 14.1x = 108 708 €
Range: 72 485€ - 146 677€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 180 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE BOBAY JEGAT with other companies in the same sector:

Frequently asked questions about PHARMACIE BOBAY JEGAT

What is the revenue of PHARMACIE BOBAY JEGAT ?

The revenue of PHARMACIE BOBAY JEGAT in 2016 is 1.0 M€.

Is PHARMACIE BOBAY JEGAT profitable?

Yes, PHARMACIE BOBAY JEGAT generated a net profit of 8 k€ in 2020.

Where is the headquarters of PHARMACIE BOBAY JEGAT ?

The headquarters of PHARMACIE BOBAY JEGAT is located in FALAISE (14700), in the department Calvados.

Where to find the tax return of PHARMACIE BOBAY JEGAT ?

The tax return of PHARMACIE BOBAY JEGAT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE BOBAY JEGAT operate?

PHARMACIE BOBAY JEGAT operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.